Literature DB >> 18721844

Lack of evidence to support the glyoxalase 1 gene (GLO1) as a risk gene of autism in Han Chinese patients from Taiwan.

Yu-Yu Wu1, Wei-Hsien Chien, Yu-Shu Huang, Susan Shur-Fen Gau, Chia-Hsiang Chen.   

Abstract

PURPOSE: Previous studies have revealed inconsistent findings regarding the association between the glyoxalase 1 protein (GLO1) gene and autism. This study aimed to replicate the genetic association of the C419A of the GLO1 gene with autism and to perform mutation screening of all the exons of the GLO1 gene in a sample of Han Chinese patients with autism from Taiwan.
METHODS: The sample included 272 patients with autism and 310 healthy controls. All the exons and the promoter region of the GLO1 gene were PCR-amplified and sequenced for mutation screening and genotyping.
RESULTS: We did not find significant differences of allelic and genotypic frequency distributions of C419A between the autism and control groups. Moreover, we did not identify any other mutations in the exon regions associated with autism in this sample. We discovered two single nucleotide polymorphisms (SNPs) at the 5' untranslated region of the GLO1 gene, designated g.-264T/G and g.-7T/C; however, these two SNPs were not associated with autism in this sample. Further analysis of halplotypes constructed from these 3 SNPs (g.-264T/G, g.-7T/C, and C419A) found no haplotype associated with autism. Our sample size has the power of 0.57 and 0.94 to detect a small effect (0.1) in the genotype and allele frequency distributions at the alpha level of 0.05, respectively.
CONCLUSIONS: Our findings suggest that the GLO1 gene is unlikely a major susceptible gene for autism in an ethnic Chinese population from Taiwan.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18721844     DOI: 10.1016/j.pnpbp.2008.07.019

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  6 in total

1.  Glyoxalase I polymorphism rs2736654 causing the Ala111Glu substitution modulates enzyme activity--implications for autism.

Authors:  Madhabi Barua; Edmund C Jenkins; Wenqiang Chen; Salomon Kuizon; Raju K Pullarkat; Mohammed A Junaid
Journal:  Autism Res       Date:  2011-04-12       Impact factor: 5.216

2.  Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders.

Authors:  Yeni Kim; Krishna C Vadodaria; Zsolt Lenkei; Tadafumi Kato; Fred H Gage; Maria C Marchetto; Renata Santos
Journal:  Antioxid Redox Signal       Date:  2019-02-01       Impact factor: 8.401

3.  Weak association of glyoxalase 1 (GLO1) variants with autism spectrum disorder.

Authors:  Jernej Kovač; Katarina Trebušak Podkrajšek; Marta Macedoni Lukšič; Tadej Battelino
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-03-27       Impact factor: 4.785

Review 4.  Glo1 inhibitors for neuropsychiatric and anti-epileptic drug development.

Authors:  Katherine M J McMurray; Margaret G Distler; Preetpal S Sidhu; James M Cook; Leggy A Arnold; Abraham A Palmer; Leigh D Plant
Journal:  Biochem Soc Trans       Date:  2014-04       Impact factor: 5.407

5.  A common and unstable copy number variant is associated with differences in Glo1 expression and anxiety-like behavior.

Authors:  Richard Williams; Jackie E Lim; Bettina Harr; Claudia Wing; Ryan Walters; Margaret G Distler; Meike Teschke; Chunlei Wu; Tim Wiltshire; Andrew I Su; Greta Sokoloff; Lisa M Tarantino; Justin O Borevitz; Abraham A Palmer
Journal:  PLoS One       Date:  2009-03-06       Impact factor: 3.240

6.  Role of Glyoxalase 1 (Glo1) and methylglyoxal (MG) in behavior: recent advances and mechanistic insights.

Authors:  Margaret G Distler; Abraham A Palmer
Journal:  Front Genet       Date:  2012-11-19       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.